BOM:508869 (India)
Â
Ordinary Shares
₹
8,960
-26.4 (-0.29%)
Jul 31
Business Description
Apollo Hospitals Enterprise Ltd
ISIN : INE437A01024
Share Class Description:
BOM:508869: Ordinary SharesTotal Employee Number:
42,497Compare
Compare
Traded in other countries / regions
APOLLOHOSP.India IPO Date
2000-04-24Description
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.28 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.9 | |||||
Debt-to-EBITDA | 2.13 | |||||
Interest Coverage | 6.44 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 7.84 | |||||
Beneish M-Score | -2.46 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.3 | |||||
3-Year EBITDA Growth Rate | 24.4 | |||||
3-Year EPS without NRI Growth Rate | 33.7 | |||||
3-Year FCF Growth Rate | 53.2 | |||||
3-Year Book Growth Rate | 15.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 24.73 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 16.04 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 62.72 | |||||
9-Day RSI | 61.43 | |||||
14-Day RSI | 61.94 | |||||
3-1 Month Momentum % | 13.73 | |||||
6-1 Month Momentum % | 24.83 | |||||
12-1 Month Momentum % | 15.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.06 | |||||
Quick Ratio | 0.98 | |||||
Cash Ratio | 0.36 | |||||
Days Inventory | 14.22 | |||||
Days Sales Outstanding | 48.06 | |||||
Days Payable | 63.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.22 | |||||
Dividend Payout Ratio | 0.15 | |||||
3-Year Dividend Growth Rate | 4.1 | |||||
Forward Dividend Yield % | 0.22 | |||||
5-Year Yield-on-Cost % | 1.96 | |||||
Shareholder Yield % | -1.23 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 48.17 | |||||
Operating Margin % | 11.47 | |||||
Net Margin % | 7.7 | |||||
EBITDA Margin % | 15.8 | |||||
FCF Margin % | 3.54 | |||||
OCF Margin % | 11.32 | |||||
ROE % | 21.75 | |||||
ROA % | 8.99 | |||||
ROIC % | 12.49 | |||||
3-Year ROIIC % | 13.33 | |||||
ROC (Joel Greenblatt) % | 25.41 | |||||
ROCE % | 19.05 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 65.99 | |||||
Forward PE Ratio | 52.35 | |||||
PE Ratio without NRI | 65.49 | |||||
Shiller PE Ratio | 131.3 | |||||
Price-to-Owner-Earnings | 53.03 | |||||
PEG Ratio | 3.03 | |||||
PS Ratio | 5.08 | |||||
PB Ratio | 13.52 | |||||
Price-to-Tangible-Book | 15.7 | |||||
Price-to-Free-Cash-Flow | 143.29 | |||||
Price-to-Operating-Cash-Flow | 44.85 | |||||
EV-to-EBIT | 43.56 | |||||
EV-to-Forward-EBIT | 34.27 | |||||
EV-to-EBITDA | 33.98 | |||||
EV-to-Forward-EBITDA | 26.99 | |||||
EV-to-Revenue | 5.36 | |||||
EV-to-Forward-Revenue | 4.02 | |||||
EV-to-FCF | 149.1 | |||||
Price-to-GF-Value | 1.01 | |||||
Price-to-Projected-FCF | 6.97 | |||||
Price-to-DCF (Earnings Based) | 2.76 | |||||
Price-to-DCF (FCF Based) | 15.53 | |||||
Price-to-Peter-Lynch-Fair-Value | 4.35 | |||||
Price-to-Graham-Number | 6.78 | |||||
Earnings Yield (Greenblatt) % | 2.3 | |||||
FCF Yield % | 0.71 | |||||
Forward Rate of Return (Yacktman) % | 20.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Apollo Hospitals Enterprise Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 252,285 | ||
| EPS (TTM) (₹) | 134.99 | ||
| Beta | 0.7151 | ||
| 3-Year Sharpe Ratio | 0.62 | ||
| 3-Year Sortino Ratio | 1.04 | ||
| Volatility % | 18.55 | ||
| 14-Day RSI | 61.94 | ||
| 14-Day ATR (₹) | 139.790033 | ||
| 20-Day SMA (₹) | 8878.05 | ||
| 12-1 Month Momentum % | 15.93 | ||
| 52-Week Range (₹) | 6680 - 9099.95 | ||
| Shares Outstanding (Mil) | 143.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Apollo Hospitals Enterprise Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Apollo Hospitals Enterprise Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-11-06 10:20 | In 96 days | ||
| Second quarter earnings results for 2027 | 2026-11-06 | In 95 days | ||
| General meeting for 2026 | 2026-08-28 10:15 | In 26 days | ||
| INR 10.000000 Cash Dividend | 2026-08-14 | In 11 days | ||
| First quarter earnings conference call for 2027 | 2026-08-13 15:00 | In 11 days | ||
| First quarter earnings results for 2027 | 2026-08-13 | In 10 days | ||
| Annual report for 2026 | 2026-08-06 | In 3 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-21 15:00 | 8,066.25 (+1.52%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-21 | 8,066.25 (+1.52%) | ||
| INR 10.000000 Cash Dividend | 2026-02-16 | 7,538.25 (+4.45%) |
Show
Entries
Apollo Hospitals Enterprise Ltd Frequently Asked Questions
What is Apollo Hospitals Enterprise Ltd(BOM:508869)'s stock price today?
The current price of BOM:508869 is ₹8960.00. The 52 week high of BOM:508869 is ₹9099.95 and 52 week low is ₹6680.00.
When is next earnings date of Apollo Hospitals Enterprise Ltd(BOM:508869)?
The next earnings date of Apollo Hospitals Enterprise Ltd(BOM:508869) is 2026-08-13.
Does Apollo Hospitals Enterprise Ltd(BOM:508869) pay dividends? If so, how much?
The Dividend Yield %  of Apollo Hospitals Enterprise Ltd(BOM:508869) is 0.22% (As of Today), Highest Dividend Payout Ratio of Apollo Hospitals Enterprise Ltd(BOM:508869) was 0.65. The lowest was 0.04. And the median was 0.25. The  Forward Dividend Yield % of Apollo Hospitals Enterprise Ltd(BOM:508869) is 0.22%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Apollo Hospitals Enterprise Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers